MS news: February 2014
The positives so far… Relapsing-Remitting Multiple Sclerosis Drug Copaxone Gets FDA Approval For Bigger Dose, Fewer Injections BioNews Texas – Copaxone injection for relapsing-remitting multiple sclerosis There is new news regarding a widely-used treatment for Relapsing-Remitting Multiple Sclerosis. According to the latest reports released by Teva Pharmaceutical Industries, the FDA has approved the company’s concentrated 3-times-per-week formulations of Copaxone, and that the formulation will now be available in 40 mg dosages. Secondary Progressive MS Trial of Lamotrigine Tested For Neuroprotection Benefits BioNews Texas – The research team proposed that delaying nerve cell destruction can limit the rate of disability in secondary progressive MS patients. The supporting study, which was completed after two years of testing, was aimed at employing nerve cell blockers like lamotrigine to monitor the rate of worsening disability…
MS News: January 2014
Primary Progressive, Relapse-Free Secondary Progressive Multiple … BioNews Texas – secondary progressive multiple sclerosis nerve While there have been a number of success stories for MS research in 2013, last year saw yet another … Gov candidates cool to more marijuana legalization Kansas City Star – Most Republicans said it was too early to decide, but a Republican candidate for lieutenant governor who suffers from multiple sclerosis said it should …
Now what?!
Life with MS. You never wake up alone. In the first five minutes of waking up, facial pain pulls my left cheek west, while my eye wants to move north, and my scalp just seems oblivious to any sensation at all. Fantastic! Just the way I want to feel on any given day! NOT. Today, however, I want to feel as bad as I possibly could.
A powerful letter to my MS
"I thought you were just another Monday morning case when you walked in," my consultant said, followed by lots of apologies and the promise that I would be very well taken care of."
A future without chronic illness
I could think of many dates, funny ones, productive ones and those that would mean to a lot of friends and family. If I could choose though, I’d want to be there when a cure for MS is found. Two million people worldwide are living with this incurable illness in their brain and spinal cord, leading to disabilities that maim them or make them withdraw from society, even life.
A future without chronic illness
Oops! This page has moved to A future without chronic illness Why not read one of these posts when you’re finished? A powerful letter to my MS MS anxiety Do I have stupid written on my forehead? I’m an ex and I’m loving it! You will survive! Responsibility hurts Ignorance Let’s be frank Fake it ’til you make it Use it or lose it! Are you getting enough? Hope cures old wounds The five-second MS rant Books, great medicine! MS, a lesson in minimalism Death, a fearful thing Balancing life and a chronic illness Updated: May 16th, 2018 ©Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2018
MS News: December 2013
With a bit of a delay, here is the good news in MS-world that found its way to the media in December 2013! Provincial MS strategy applauded Announced Nov. 25, Health Minister Fred Horne said the strategy – The Way Forward – “connects the dots” in the health care system so that Alberta’s almost 14,000 multiple sclerosis (MS) patients can access resources and find supports more easily. Teva and Takeda Announce Agreement for Glatiramer Acetate for Multiple Sclerosis Treatment in Japan Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda Pharmaceutical Company Limited (Takeda) today announced the signing earlier this year of an agreement in which Teva licensed to Takeda the right to commercialize Teva’s innovative glatiramer acetate (active ingredient) formulation for the treatment of multiple sclerosis, in Japan. Teva and Takeda…
